Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

Journal of General Virology

Volumn 94, Issue PART11, 2013, Pages 143-149

  Cento, Valeria ^a   Mirabelli, Carmen ^a   Dimonte, Salvatore ^a   Salpini, Romina ^a   Han, Yue ^b   Trimoulet, Pascale ^c   Bertoli, Ada ^d   Micheli, Valeria ^e   Gubertini, Guido ^f   Cappiello, Giuseppina ^f   Spanò, Alberto ^f   Longo, Roberta ^f   Bernassola, Martina ^f   Mazzotta, Francesco ^g   De Sanctis, Giuseppe Maria ^h   Zhang, Xin Xin ^b   Verheyen, Jens ⁱ   Monforte, Antonella D'Arminio ^j   Ceccherini Silberstein, Francesca ^a   Perno, Carlo Federico ^a   Svicher, Valentina ^a   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SANDRO PERTINI HOSPITAL   (Italy)

^g Hospital Santa Maria Annunziata   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; NUCLEOTIDE; RNA DIRECTED DNA POLYMERASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONSERVATION GENETICS; CONTROLLED STUDY; GENE LOCATION; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; GENETIC CONSERVATION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MIXED INFECTION; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; VIRUS GENOME; VIRUS IMMUNITY; VIRUS MUTATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; COINFECTION; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RNA-DIRECTED DNA POLYMERASE;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84871331710     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.046524-0     Document Type: Article

References (25)

1. Balzarini, J. (2007). Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 5, 583-597.
2. Blanchet, M. & Sureau, C. (2006). Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80, 11935-11945.
3. Chang, M. H. (2010). Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther 15 (3 Pt B), 463-469.
4. Chisari, F. V., Isogawa, M. & Wieland, S. F. (2010). Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58, 258-266.
5. Das, K., Xiong, X., Yang, H., Westland, C. E., Gibbs, C. S., Sarafianos, S. G. & Arnold, E. (2001). Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J Virol 75, 4771-4779.
6. Desmond, C. P., Bartholomeusz, A., Gaudieri, S., Revill, P. A. & Lewin, S. R. (2008). A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir Ther 13, 161-175.
7. François, K. O. & Balzarini, J. (2012). Potential of carbohydratebinding agents as therapeutics against enveloped viruses. Med Res Rev 32, 349-387.
8. Gish, R. G., Satishchandran, C., Young, M. & Pachuk, C. (2011). RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study. Antivir Ther 16, 547-554.
9. Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A. & Steitz, T. A. (1992). Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
10. Lai, M. W., Lin, T. Y., Tsao, K. C., Huang, C. G., Hsiao, M. J., Liang, K. H. & Yeh, C. T. (2012). Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology 143, 400-407.
11. Locarnini, S. A. & Yuen, L. (2010). Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther 15 (3 Pt B), 451-461.
12. Lok, A. S. & McMahon, B. J. (2009). Chronic hepatitis B: update 2009. Hepatology 50, 661-662.
13. Maman, Y., Blancher, A., Benichou, J., Yablonka, A., Efroni, S. & Louzoun, Y. (2011). Immune-induced evolutionary selection focused on a single reading frame in overlapping hepatitis B virus proteins. J Virol 85, 4558-4566.
14. McMahon, B. J. (2004). Viral hepatitis in the Arctic. Int J Circumpolar Health 63 (Suppl. 2), 41-48.
15. McMahon, B. J. (2009). The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 3, 334-342.
16. Mizokami, M. & Orito, E. (1999). Molecular evolution of hepatitis viruses. Intervirology 42, 159-165.
17. Mizokami, M., Orito, E., Ohba, K., Ikeo, K., Lau, J. Y. & Gojobori, T. (1997). Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 44 (Suppl. 1), S83-S90.
18. Pond, S. L., Frost, S. D. & Muse, S. V. (2005). HyPhy: hypothesis testing using phylogenies. Bioinformatics 21, 676-679.
19. Torresi, J., Earnest-Silveira, L., Deliyannis, G., Edgtton, K., Zhuang, H., Locarnini, S. A., Fyfe, J., Sozzi, T. & Jackson, D. C. (2002). Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293, 305-313.
20. van der Sande, M. A., Waight, P., Mendy, M., Rayco-Solon, P., Hutt, P., Fulford, T., Doherty, C., McConkey, S. J., Jeffries, D. & other authors (2006). Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 193, 1528-1535.
21. WHO (2012). HBV Fact Sheet no. 204, July 2012. http://www.who.int/mediacentre/factsheets/fs204/en/
22. Yang, Z. (2007). PAML4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24, 1586-1591.
23. Yang, Z., Lauder, I. J. & Lin, H. J. (1995). Molecular evolution of the hepatitis B virus genome. J Mol Evol 41, 587-596.
24. Zaaijer, H. L., van Hemert, F. J., Koppelman, M. H. & Lukashov, V. V. (2007). Independent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol 88, 2137-2143.
25. Zhang, Y. L., Cheng, T., Cai, Y. J., Yuan, Q., Liu, C., Zhang, T., Xia, D. Z., Li, R. Y., Yang, L. W. & other authors (2010). RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol 10, 214.